COMMONWEALTH EQUITY SERVICES, LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 89 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2021$12,000
-47.8%
11,978
-5.0%
0.00%
Q2 2021$23,000
-4.2%
12,6030.0%0.00%
Q1 2021$24,000
+20.0%
12,603
-23.8%
0.00%
Q4 2020$20,000
-37.5%
16,543
-9.0%
0.00%
Q3 2020$32,000
-68.3%
18,174
+50.1%
0.00%
Q2 2020$101,00012,1050.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$27,550,00020.34%
AdvisorShares Investments LLC 380,750$2,079,0001.29%
ETF MANAGERS GROUP, LLC 5,779,642$31,557,0001.10%
DAFNA Capital Management LLC 297,300$1,623,0000.56%
GENERAL AMERICAN INVESTORS CO INC 632,400$3,453,0000.32%
Aries Wealth Management 27,900$160,0000.10%
Virtus ETF Advisers LLC 81,751$446,0000.07%
Omnia Family Wealth, LLC 21,726$119,0000.06%
HighVista Strategies LLC 12,200$67,0000.05%
WOODSTOCK CORP 57,213$312,0000.05%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders